Replies to post #42646 on Elite Pharmaceuticals Inc (ELTP)

[Aqua]

I agree that pennies are risky. Nothing in the equity markets are a sure bet. Many here realize the risks but also realize the profit potential of speculation. A savy investor would know her entry point and have a exit strategy. To keep everyone honest, the due diligence speaks for itself objectively and increase the probability of a successful or failed bet. Before placing your bets, always determine if you would proceed long-term or short-term for this stock. For instance, the investor who said she is down 6-cents would perceive her investment as a loss because her mindset is for the short-term while the long-term investor would be elated by the cheaper shares and see the low share prices as an opportunity to average down to maximize her future gains. Taking a long-term approach is indeed flexible and allows time for your bet to play out. Cheers!

[Couch]

If you do some solid DD you realize the risky period was in 2011 when Elite had Lodrane D pulled from the market. The company now has 5 products on the market.....2 additional doses of Phentermine Capsules launching by the end of the month.....Naltrexone pending FDA approval of site move, a 100% owned Anda pending approval and several other products including NDA's in development. Here is the list in Elite's pipeline.
http://www.elitepharma.com/product_pipeline.asp

There is little risk involved at this point in time witnessed by the most recent SEC quarterly report"

Consolidated revenues were $0.6 million for the quarter, an increase of 131% when compared to the comparable quarter of the prior year. This increase is the result of the continuing growth of the new revenue streams that have been created within the last eighteen months.

Just like previously, that requires us to get to an annual run rate of a little over $4 million, and Carter can correct me if I'm wrong about that, but I think that's correct. We are getting there; we're definitely getting there. With a little help from the FDA, we will get there in fiscal 2013.